Arcus Biosciences
RCUS
RCUS
78 hedge funds and large institutions have $210M invested in Arcus Biosciences in 2019 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 27 increasing their positions, 12 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
78
Holders Change
+14
Holders Change %
+21.88%
% of All Funds
1.7%
Holding in Top 10
3
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-40%
% of All Funds
0.07%
New
19
Increased
27
Reduced
12
Closed
3
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
BI
1
BVF Inc
San Francisco,
California
|
$28.1M |
| 2 |
EC
2
EcoR1 Capital
San Francisco,
California
|
$11.8M |
| 3 |
3
BlackRock
New York
|
$17.8M |
| 4 |
4
Nuveen Asset Management
Chicago,
Illinois
|
$1.06M |
| 5 |
5
Morgan Stanley
New York
|
$785K |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
APA
76
American Portfolios Advisors
Holbrook,
New York
| $1.99K | – | – | – |
|
|
TI
77
Trexquant Investment
Stamford,
Connecticut
| – | -$204K | -16,361 | Closed |
|
78
SG Americas Securities
New York
| – | -$110K | -8,782 | Closed |
|
|
TRCT
79
Tower Research Capital (TRC)
New York
| – | -$61K | -4,870 | Closed |
|